Best Stocks Under $5 | Low-Priced Stocks for Five Dollars or Less

1. Ur Energy NYSEAMERICAN:URG

$1.34 -0.04 (-2.90%)

Closing price 04:10 PM Eastern

Extended Trading

$1.34 -0.01 (-0.37%)

As of 07:52 PM Eastern

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization: $548.39 million
Consensus Rating: Buy
Consensus Price Target: $2.32 (+72.9% Upside)
Volume: 4.39 million shares
Average Volume: 4.95 million shares
Today's Range: $1.33
▼
$1.38

2. CuriosityStream NASDAQ:CURI

$2.71 +0.11 (+4.23%)

Closing price 04:00 PM Eastern

Extended Trading

$2.68 -0.02 (-0.92%)

As of 07:30 PM Eastern

CuriosityStream Inc operates as a factual content streaming service and media company. The company provides premium video and audio programming services in various categories of factual entertainment, including science, history, society, nature, lifestyle, and technology through direct subscription video on-demand (SVoD) platforms accessible by internet connected devices, or indirectly via distribution partners who deliver CuriosityStream content via distributor's platform or system, as well as through bundled content licenses for SVoD and linear offerings, talks and courses, and partner bulk sales. More about CuriosityStream

Market Capitalization: $154.28 million
P/E Ratio: 271.00
Consensus Rating: Buy
Consensus Price Target: $5.50 (+103.0% Upside)
Volume: 605,711 shares
Average Volume: 2.27 million shares

3. Nouveau Monde Graphite NYSE:NMG

$1.34 -0.03 (-2.48%)

Closing price 03:58 PM Eastern

Extended Trading

$1.37 +0.03 (+2.62%)

As of 07:00 PM Eastern

Nouveau Monde Graphite Inc engages in the acquisition, exploration, development, and evaluation of mineral properties in Quebec, Canada. More about Nouveau Monde Graphite

Market Capitalization: $220.33 million
Consensus Rating: Buy
Consensus Price Target: $4.67 (+249.3% Upside)
Volume: 297,048 shares
Average Volume: 373,038 shares
Today's Range: $1.33
▼
$1.37

4. iBio NASDAQ:IBIO

$1.23 -0.04 (-2.78%)

Closing price 04:00 PM Eastern

Extended Trading

$1.27 +0.04 (+3.59%)

As of 07:55 PM Eastern

iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBio

Market Capitalization: $81.03 million
Consensus Rating: Buy
Consensus Price Target: $5.00 (+308.2% Upside)
Volume: 308,945 shares
Average Volume: 736,857 shares
Today's Range: $1.22
▼
$1.26

5. Larimar Therapeutics NASDAQ:LRMR

$3.85 -0.02 (-0.52%)

Closing price 04:00 PM Eastern

Extended Trading

$3.86 +0.00 (+0.13%)

As of 07:55 PM Eastern

Larimar Therapeutics, Inc, a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. More about Larimar Therapeutics

Market Capitalization: $402.03 million
Consensus Rating: Buy
Consensus Price Target: $11.67 (+203.0% Upside)
Volume: 870,887 shares
Average Volume: 850,279 shares
Today's Range: $3.74
▼
$3.86

6. Inventiva NASDAQ:IVA

$4.14 -0.31 (-6.97%)

Closing price 04:00 PM Eastern

Extended Trading

$4.33 +0.19 (+4.59%)

As of 06:42 PM Eastern

Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. More about Inventiva

Market Capitalization: $924.30 million
Consensus Rating: Buy
Consensus Price Target: $15.38 (+271.4% Upside)
Volume: 808,183 shares
Average Volume: 817,444 shares
Today's Range: $4.13
▼
$4.41

7. Galiano Gold NYSEAMERICAN:GAU

$2.16 -0.08 (-3.57%)

Closing price 04:10 PM Eastern

Extended Trading

$2.13 -0.03 (-1.34%)

As of 07:56 PM Eastern

Galiano Gold Inc engages in the exploration and evaluation of gold properties in Canada. Its flagship asset is the Asanko Gold Mine that covers an area of approximately 21,000 hectares located in Ghana, West Africa. More about Galiano Gold

Market Capitalization: $585.82 million
P/E Ratio: 8.31
Consensus Rating: Buy
Consensus Price Target: $4.25 (+96.8% Upside)
Volume: 2.15 million shares
Average Volume: 2.66 million shares

8. Niagen Bioscience NASDAQ:NAGE

$3.04 -0.01 (-0.33%)

Closing price 04:00 PM Eastern

Extended Trading

$3.06 +0.02 (+0.79%)

As of 07:30 PM Eastern

Niagen Bioscience, Inc is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. More about Niagen Bioscience

Market Capitalization: $242.91 million
P/E Ratio: 16.89
Consensus Rating: Buy
Consensus Price Target: $10.33 (+239.9% Upside)
Volume: 276,564 shares
Average Volume: 397,956 shares

9. Uranium Royalty NASDAQ:UROY

$4.50 -0.30 (-6.25%)

Closing price 04:00 PM Eastern

Extended Trading

$4.53 +0.03 (+0.58%)

As of 07:53 PM Eastern

Uranium Royalty Corp. operates as a pure-play uranium royalty company. It acquires, accumulates, and manages a portfolio of geographically diversified uranium interests. More about Uranium Royalty

Market Capitalization: $1.83 billion
P/E Ratio: 225.11
Consensus Rating: Buy
Consensus Price Target: $4.13 (-8.3% Downside)
Volume: 3.39 million shares
Average Volume: 2.43 million shares

10. Palisade Bio NASDAQ:PALI

$2.01 -0.04 (-1.95%)

Closing price 04:00 PM Eastern

Extended Trading

$2.04 +0.04 (+1.74%)

As of 07:30 PM Eastern

Palisade Bio, Inc, a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. More about Palisade Bio

Market Capitalization: $357.26 million
Consensus Rating: Buy
Consensus Price Target: $9.00 (+347.8% Upside)
Volume: 2.65 million shares
Average Volume: 1.64 million shares
Today's Range: $2.01
▼
$2.11

11. Inhibikase Therapeutics NASDAQ:IKT

$2.33 -0.08 (-3.32%)

Closing price 04:00 PM Eastern

Extended Trading

$2.34 +0.00 (+0.21%)

As of 07:30 PM Eastern

Inhibikase Therapeutics, Inc, a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. More about Inhibikase Therapeutics

Market Capitalization: $336.28 million
Consensus Rating: Buy
Consensus Price Target: $5.40 (+131.8% Upside)
Volume: 332,368 shares
Average Volume: 376,901 shares
Today's Range: $2.32
▼
$2.39

12. Lexeo Therapeutics NASDAQ:LXEO

$4.36 -0.12 (-2.68%)

Closing price 04:00 PM Eastern

Extended Trading

$4.52 +0.16 (+3.67%)

As of 07:30 PM Eastern

Lexeo Therapeutics, Inc operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. More about Lexeo Therapeutics

Market Capitalization: $367.57 million
Consensus Rating: Buy
Consensus Price Target: $18.75 (+330.0% Upside)
Volume: 420,870 shares
Average Volume: 623,516 shares
Today's Range: $4.31
▼
$4.44

13. Stereotaxis NYSEAMERICAN:STXS

$1.30 -0.02 (-1.52%)

Closing price 04:10 PM Eastern

Extended Trading

$1.32 +0.02 (+1.77%)

As of 07:56 PM Eastern

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More about Stereotaxis

Market Capitalization: $132.27 million
Consensus Rating: Buy
Consensus Price Target: $3.50 (+169.2% Upside)
Volume: 625,295 shares
Average Volume: 487,377 shares
Today's Range: $1.27
▼
$1.33

14. Perspective Therapeutics NYSEAMERICAN:CATX

$2.77 -0.22 (-7.36%)

Closing price 04:10 PM Eastern

Extended Trading

$2.86 +0.10 (+3.43%)

As of 07:39 PM Eastern

Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective Therapeutics

Market Capitalization: $341.31 million
Consensus Rating: Buy
Consensus Price Target: $11.50 (+315.2% Upside)
Volume: 1.58 million shares
Average Volume: 980,710 shares
Today's Range: $2.75
▼
$3.01

15. Immuneering NASDAQ:IMRX

$4.57 -0.04 (-0.87%)

Closing price 04:00 PM Eastern

Extended Trading

$4.65 +0.08 (+1.73%)

As of 07:30 PM Eastern

Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. More about Immuneering

Market Capitalization: $298.26 million
Consensus Rating: Buy
Consensus Price Target: $17.50 (+282.9% Upside)
Volume: 623,957 shares
Average Volume: 621,096 shares
Today's Range: $4.47
▼
$4.69

16. Compugen NASDAQ:CGEN

$2.46 -0.02 (-0.81%)

Closing price 04:00 PM Eastern

Extended Trading

$2.46 0.00 (-0.20%)

As of 07:30 PM Eastern

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. More about Compugen

Market Capitalization: $234.49 million
P/E Ratio: 6.47
Consensus Rating: Buy
Consensus Price Target: $5.00 (+103.3% Upside)
Volume: 206,982 shares
Average Volume: 298,103 shares

17. Equillium NASDAQ:EQ

$2.42 -0.14 (-5.47%)

Closing price 04:00 PM Eastern

Extended Trading

$2.34 -0.08 (-3.31%)

As of 07:48 PM Eastern

Equillium, Inc, a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. More about Equillium

Market Capitalization: $162.32 million
Consensus Rating: Moderate Buy
Consensus Price Target: $7.57 (+212.9% Upside)
Volume: 397,312 shares
Average Volume: 397,479 shares
Today's Range: $2.41
▼
$2.69

18. Ovid Therapeutics NASDAQ:OVID

$2.63 -0.07 (-2.59%)

Closing price 04:00 PM Eastern

Extended Trading

$2.66 +0.02 (+0.95%)

As of 07:51 PM Eastern

Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid Therapeutics

Market Capitalization: $527.30 million
Consensus Rating: Moderate Buy
Consensus Price Target: $5.86 (+122.7% Upside)
Volume: 1.40 million shares
Average Volume: 1.44 million shares
Today's Range: $2.61
▼
$2.70

19. Prime Medicine NASDAQ:PRME

$3.35 -0.12 (-3.46%)

Closing price 04:00 PM Eastern

Extended Trading

$3.37 +0.02 (+0.63%)

As of 07:47 PM Eastern

We are a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, Prime Editors, to address the widest spectrum of diseases by deploying our Prime Editing technology, which we believe is a versatile, precise, efficient and broad gene editing technology. More about Prime Medicine

Market Capitalization: $629.38 million
Consensus Rating: Moderate Buy
Consensus Price Target: $7.47 (+123.1% Upside)
Volume: 2.39 million shares
Average Volume: 2.56 million shares
Today's Range: $3.31
▼
$3.42

20. Aquestive Therapeutics NASDAQ:AQST

$4.99 -0.16 (-3.11%)

Closing price 04:00 PM Eastern

Extended Trading

$4.96 -0.04 (-0.70%)

As of 07:48 PM Eastern

Aquestive Therapeutics, Inc operates as a pharmaceutical company in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. More about Aquestive Therapeutics

Market Capitalization: $646.39 million
Consensus Rating: Moderate Buy
Consensus Price Target: $9.17 (+83.7% Upside)
Volume: 3.28 million shares
Average Volume: 2.98 million shares
Today's Range: $4.92
▼
$5.30

21. Foghorn Therapeutics NASDAQ:FHTX

$4.49 -0.18 (-3.85%)

Closing price 04:00 PM Eastern

Extended Trading

$4.44 -0.05 (-1.11%)

As of 07:30 PM Eastern

Foghorn Therapeutics Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. More about Foghorn Therapeutics

Market Capitalization: $277.33 million
Consensus Rating: Moderate Buy
Consensus Price Target: $11.43 (+154.5% Upside)
Volume: 396,829 shares
Average Volume: 368,616 shares
Today's Range: $4.46
▼
$4.65

22. Compass Therapeutics NASDAQ:CMPX

$2.05 -0.13 (-5.96%)

Closing price 04:00 PM Eastern

Extended Trading

$2.08 +0.03 (+1.46%)

As of 07:55 PM Eastern

Compass Therapeutics, Inc, a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. More about Compass Therapeutics

Market Capitalization: $392.59 million
Consensus Rating: Moderate Buy
Consensus Price Target: $11.77 (+474.1% Upside)
Volume: 2.54 million shares
Average Volume: 2.20 million shares
Today's Range: $2.04
▼
$2.17

23. Gold Royalty NYSEAMERICAN:GROY

$3.28 -0.01 (-0.30%)

Closing price 04:10 PM Eastern

Extended Trading

$3.30 +0.02 (+0.61%)

As of 07:30 PM Eastern

Gold Royalty Corp., a precious metals-focused royalty company, provides financing solutions to the metals and mining industry. More about Gold Royalty

Market Capitalization: $759.36 million
P/E Ratio: 328.33
Consensus Rating: Moderate Buy
Consensus Price Target: $5.64 (+72.0% Upside)
Volume: 2.10 million shares
Average Volume: 1.92 million shares

24. Autolus Therapeutics NASDAQ:AUTL

$1.96 -0.07 (-3.45%)

Closing price 04:00 PM Eastern

Extended Trading

$1.96 0.00 (0.00%)

As of 07:35 PM Eastern

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. More about Autolus Therapeutics

Market Capitalization: $540.31 million
Consensus Rating: Moderate Buy
Consensus Price Target: $10.00 (+410.2% Upside)
Volume: 1.33 million shares
Average Volume: 2.22 million shares
Today's Range: $1.95
▼
$2.02

25. Denison Mine NYSEAMERICAN:DNN

$3.23 -0.12 (-3.58%)

Closing price 04:10 PM Eastern

Extended Trading

$3.24 +0.01 (+0.37%)

As of 07:56 PM Eastern

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mine

Market Capitalization: $3.03 billion
Consensus Rating: Moderate Buy
Consensus Price Target: $5.38 (+66.4% Upside)
Volume: 15.62 million shares
Average Volume: 26.04 million shares
Today's Range: $3.21
▼
$3.30

Best Stocks Under $5 Right Now

1. Ur Energy NYSEAMERICAN:URG

2. CuriosityStream NASDAQ:CURI

3. Nouveau Monde Graphite NYSE:NMG

4. iBio NASDAQ:IBIO

5. Larimar Therapeutics NASDAQ:LRMR

6. Inventiva NASDAQ:IVA

7. Galiano Gold NYSEAMERICAN:GAU

8. Niagen Bioscience NASDAQ:NAGE

9. Uranium Royalty NASDAQ:UROY

10. Palisade Bio NASDAQ:PALI

11. Inhibikase Therapeutics NASDAQ:IKT

12. Lexeo Therapeutics NASDAQ:LXEO

13. Stereotaxis NYSEAMERICAN:STXS

14. Perspective Therapeutics NYSEAMERICAN:CATX

15. Immuneering NASDAQ:IMRX

16. Compugen NASDAQ:CGEN

17. Equillium NASDAQ:EQ

18. Ovid Therapeutics NASDAQ:OVID

19. Prime Medicine NASDAQ:PRME

20. Aquestive Therapeutics NASDAQ:AQST

21. Foghorn Therapeutics NASDAQ:FHTX

22. Compass Therapeutics NASDAQ:CMPX

23. Gold Royalty NYSEAMERICAN:GROY

24. Autolus Therapeutics NASDAQ:AUTL

25. Denison Mine NYSEAMERICAN:DNN

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Best Stocks Under $5 Right Now

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools